TYPE-1 DIABETES-MELLITUS AND HOMOCYST(E)INE

被引:0
|
作者
ROBILLON, JF
CANIVET, B
CANDITO, M
SADOUL, JL
JULLIEN, D
MORAND, P
CHAMBON, P
FREYCHET, P
机构
[1] CHU NICE,HOP LOUIS PASTEUR,DEPT BIOCHEM,F-06002 NICE 1,FRANCE
[2] CHU NICE,HOP LOUIS PASTEUR,DEPT CARDIOVASC DIS,F-06002 NICE 1,FRANCE
来源
DIABETES & METABOLISM | 1994年 / 20卷 / 05期
关键词
HOMOCYST(E)INE; TYPE 1 DIABETES (IDDM); ATHEROSCLEROSIS; VASCULAR RISK FACTOR;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
High Homocyst(e)ine levels (H) have been recently recognized as a risk factor for atherosclerosis. Patients with Diabetes Mellitus (DM) are prone to atherosclerosis. Therefore, this study was designed to search for the effect of DM on H and their relationship. Forty-one Type 1 diabetic subjects (DS, age 34.8 +/- 12 yr, DM duration : 10.7 +/- 11.1 yr) were compared to 40 age-matched control subjects (CS, age 34.2 +/- 9.1 yr). H (measured by ion-exchange chromatography, units : mu mol/l) and several parameters (creatininaemia; triglycerides; total, HDL, LDL cholesterol; Lp(a); HbA1c; vitamins B9 and B12) were determined after an overnight fast. H were significantly (p = 0.0001) lower in DS (6.8 +/- 2.2) than in CS (9.5 +/- 2.9). This difference was still apparent in male and female subgroups compared to matched CS (p = 0.003 for each). No correlation was found between H and : lipids, vitamins, renal or retinal status. But H seemed to increase with age, especially in women (p = 0.03; r = 0.32). While there is, at this time, no explanation for the lower H observed in DS, it appears that H cannot directly account for accelerated atherosclerosis in DM. Nevertheless, it remains to be established if high, or even normal, H could identify a subgroup of DS at higher risk of precocious and severe atherosclerosis.
引用
收藏
页码:494 / 496
页数:3
相关论文
共 50 条
  • [31] THE DIRECT COST OF TYPE-1 DIABETES-MELLITUS IN ISRAEL
    STERN, Z
    LEVY, R
    DIABETIC MEDICINE, 1994, 11 (06) : 528 - 533
  • [32] Homocyst(e)ine and stroke
    Furie, Karen L.
    Kelly, Peter J.
    SEMINARS IN NEUROLOGY, 2006, 26 (01) : 24 - 32
  • [33] IMMUNOLOGICAL ASPECTS OF TYPE-1 AND TYPE-2 DIABETES-MELLITUS
    LERNMARK, A
    BAEKKESKOV, S
    GERLING, I
    KASTERN, W
    KNUTSON, C
    MICHELSEN, B
    ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, 1985, 189 : 107 - 127
  • [34] APOLIPOPROTEIN(A) LEVELS IN TYPE-1 AND TYPE-2 DIABETES-MELLITUS
    RUOTOLO, G
    ZOPPO, A
    PARLAVECCHIA, M
    GIBERTI, B
    MICOSSI, P
    ACTA DIABETOLOGICA, 1991, 28 (02) : 158 - 161
  • [35] GRANULOCYTIC FUNCTION IN DIABETES-MELLITUS TYPE-1 AND TYPE-2
    PERSCHEL, WT
    YILDIZ, M
    FEDERLIN, K
    IMMUNITAT UND INFEKTION, 1994, 22 (06): : 222 - 226
  • [36] A NORMAL EXERCISE RESPONSE IN UNCOMPLICATED TYPE-1 DIABETES-MELLITUS
    KELLEHER, C
    FERRISS, JB
    ROSS, H
    OSULLIVAN, DJ
    CLINICAL SCIENCE, 1986, 71 : P61 - P62
  • [37] ERYTHROCYTE-MEMBRANE FLUIDITY IN TYPE-1 DIABETES-MELLITUS
    HILL, MA
    COURT, JM
    AUSTRALIAN PAEDIATRIC JOURNAL, 1982, 18 (03): : 227 - 227
  • [38] IMMUNOINTERVENTION IN TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS
    KEYMEULEN, B
    SOMERS, G
    ACTA CLINICA BELGICA, 1993, 48 (02): : 86 - 95
  • [39] PREVALENCE OF PATHOLOGICAL TOOTHWEAR IN PATIENTS WITH TYPE-1 DIABETES-MELLITUS
    ROBB, ND
    SMITH, BGN
    WALLS, AWG
    JOURNAL OF DENTAL RESEARCH, 1990, 69 : 304 - 304
  • [40] BREAST-FEEDING AND THE DEVELOPMENT OF TYPE-1 DIABETES-MELLITUS
    KYVIK, KO
    GREEN, A
    SVENDSEN, A
    MORTENSEN, K
    DIABETIC MEDICINE, 1992, 9 (03) : 233 - 235